Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/03639045.2021.1908343 http://scihub22266oqcxt.onion/10.1080/03639045.2021.1908343 33826439!8040490!33826439     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33826439&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Dev+Ind+Pharm 2021 ; 47 (4): 673-684 Nephropedia Template TP {{tp|p=33826439|t=2021. Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines |pdf=|usr=}}{{33826439}} gab.com Text Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines JO: Drug Dev Ind Pharm http://www.kidney.de/pget.php?&tw=1&pmid=33826439 #FOAvip PURPOSE: The last two decades have seen the emergence of several viral outbreaks. Some of them are the severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome 2 (SARS-CoV2) - the cause of the coronavirus disease 2019 (COVID-19). Ever, vaccines for emergency use have been authorized for the control and prevention of COVID-19. Currently, there is an urgent need to develop a vaccine for prophylaxis of COVID-19 and for other future epidemics. METHODS: This review describes patented vaccines for SARS and MERS-CoV and vaccines developed and approved for emergency use against the new coronavirus (COVID-19). The European Patent Office and the World Intellectual Property Organization were the patent databases used using specific terms. In addition, another search was carried out in the Clinical Trials in search of ongoing clinical studies focused on the COVID-19 vaccine. RESULTS: The patent search showed that most vaccines are based on viral vector platforms, nucleic acids, or protein subunits. The review also includes an overview of completed and ongoing clinical trials for SARS-CoV-2 in several countries. CONCLUSION: The information provided here lists vaccines for other types of coronavirus that have been used in the development of vaccines for COVID-19. Twit Text FOAVip Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines ????Drug Dev Ind Pharm http://www.kidney.de/pget.php?&tw=1&pmid=33826439 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33826439 #FOAvip English Wikipedia <ref>{{Cite pmid|33826439}}</ref> Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines #MMPMID33826439 Nascimento Junior JAC; Santos AM; Cavalcante RCM; Quintans-Junior LJ; Walker CIB; Borges LP; Frank LA; Serafini MR Drug Dev Ind Pharm 2021[Apr]; 47 (4): 673-684 PMID33826439show ga PURPOSE: The last two decades have seen the emergence of several viral outbreaks. Some of them are the severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome 2 (SARS-CoV2) - the cause of the coronavirus disease 2019 (COVID-19). Ever, vaccines for emergency use have been authorized for the control and prevention of COVID-19. Currently, there is an urgent need to develop a vaccine for prophylaxis of COVID-19 and for other future epidemics. METHODS: This review describes patented vaccines for SARS and MERS-CoV and vaccines developed and approved for emergency use against the new coronavirus (COVID-19). The European Patent Office and the World Intellectual Property Organization were the patent databases used using specific terms. In addition, another search was carried out in the Clinical Trials in search of ongoing clinical studies focused on the COVID-19 vaccine. RESULTS: The patent search showed that most vaccines are based on viral vector platforms, nucleic acids, or protein subunits. The review also includes an overview of completed and ongoing clinical trials for SARS-CoV-2 in several countries. CONCLUSION: The information provided here lists vaccines for other types of coronavirus that have been used in the development of vaccines for COVID-19. |*COVID-19[MESH] |*Vaccines[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH] |RNA, Viral[MESH]Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vacc(epmc).pdf DeepDyve Pubget Overpricing